Search

Filters

Clear Filters
9:35 AM - 9:40 AM ET

1238 - Genetic Signatures Predicting Toxicity and Overall Survival in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients in RTOG 0522 Treated with Radiation and Cisplatin
Speaker: Weidhaas, Joanne, MD, PhD - UCLA Radiation Oncology, Los Angeles, CA
9:40 AM - 9:45 AM ET

1239 - Stereotactic Ablative Radiotherapy (SABR) for Early Stage Glottic Cancer: A Multi-Institutional Pooled Analysis of Long-Term Efficacy, Toxicity and Voice Outcomes
Speaker: Young, Sympascho, MD, BS - UT Southwestern Medical Center, Dallas, TX
3:30 PM - 3:40 PM ET

124 - Biology-Guided Radiotherapy In Pan-HPV Head and Neck Cancer Using Genomic-Adjusted Radiation Dose
Speaker: Bergman, Drew, MD - Memorial Sloan Kettering Cancer Center, New York, NY
9:45 AM - 9:50 AM ET

1240 - Prospective Evaluation of Daily Online Adaptive Radiotherapy with 1mm PTV Margins in High Risk HPV Negative Head and Neck Cancer
Speaker: Bajwa, Harjot, MD - American Oncology Institute, Hyderabad
9:20 AM - 9:25 AM ET

1241 - Transcriptional and Non-Transcriptional Regulation of Radiotherapy Response by LUC7L3
Speaker: Xu, Rongli, MS - Department of Radiation Oncology Cancer Institute & Hospital, Chinese Academy of Medical Science, Beijing, Beijing
9:25 AM - 9:30 AM ET

1242 - AKR1C3 Negatively Regulates the LGALS3/p62/NRF2 Axis to Inhibit Ferroptosis and Induce Radioresistance in Prostate Cancer
Speaker: Lyu, Feng, MD, PhD - Peking University First Hospital, Beijing, Beijing
9:30 AM - 9:35 AM ET

1243 - Radiation Enhances Efficacy of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer via HER2 Upregulation
Speaker: Li, Qing, MD, PhD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH
9:35 AM - 9:40 AM ET

1244 - Nanoray Pancreas: Biomarker Insights of NBTXR3 Activated by Radiotherapy (RT) for Locally Advanced or Borderline Resectable Pancreatic Cancer (LAPC or BRPC)
Speaker: Cargill, Kasey, MD, PhD - MD Anderson Cancer Center, Houston, TX
9:40 AM - 9:45 AM ET

1245 - AARS1/2-Mediated Histone Lactylation Drives an Immunosuppressive Tumor Microenvironment and Represents a Novel Target to Enhance Anti-PD-1 Therapy
Speaker: Liu, Mei - Cancer Center, Shandong University, Jinan, Shandong
9:45 AM - 9:50 AM ET

1246 - Radiotherapy under Low Glucose Triggers Disulfidptosis in SLC7A11-High Tumors by Limiting Pentose Phosphate Pathway-Derived NADPH
Speaker: Su, Mengyao - Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
9:15 AM - 9:20 AM ET

1247 - Integrating Clinical and PET Radiomics Features for Pre-Therapy Cardiac Risk Prediction
Speaker: Panchal, Devanshu, PhD - Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
9:20 AM - 9:25 AM ET

1248 - External Validation and Development of Radiomics Models for Radiation Pneumonitis after Chemoradio-Immunotherapy in Locally Advanced NSCLC
Speaker: Ebrahimpour, Leyla, PhD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ